These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6151381)

  • 1. Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
    Morales-Olivas FJ; Palop V; Rubio E; Esplugues J
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):71-8. PubMed ID: 6151381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-adrenolytic properties of bromocriptine in dogs.
    Montastruc JL; Montastruc P
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):83-90. PubMed ID: 6131651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution].
    Chamontin B; Montastruc JL; Rascol A
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1181-5. PubMed ID: 6151826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alpha-adrenoceptor antagonists administered intraventricularly on central hypotensive action of clonidine and on central hypertensive action of methoxamine in rabbits.
    Kim YI; Paik YH; Kang SS; Kim JH
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):66-76. PubMed ID: 6126161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H; Majewski H; Hedler L; Starke K
    J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057).
    Salvati P; Bianchi G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):291-304. PubMed ID: 4026460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TL-350, an ergoline derivative with dopamine receptor agonist properties.
    Ilhan M; Long JP; Bhatnagar R; Flynn J; Cannon JG; Lee T
    J Pharmacol Exp Ther; 1984 Oct; 231(1):56-60. PubMed ID: 6548524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
    Nagahama S; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
    Hirohashi M; Tanaka M; Suzuki I; Akashi A
    Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of a new antihypertensive agent in several species.
    Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of central dopamine (DA) receptors in the regulation of blood pressure.
    Jaszlits L; Tardos L; Borsy J
    Pol J Pharmacol Pharm; 1985; 37(3):405-10. PubMed ID: 4070082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of bromocriptine in rats: role of peripheral adrenergic and dopaminergic receptors.
    Roquebert J; Alaoui K; Morán Benito A
    J Auton Pharmacol; 1990 Apr; 10(2):85-96. PubMed ID: 2161850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of spinal dopamine receptors to the hypotensive action of bromocriptine in rats.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):317-25. PubMed ID: 1720830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
    Solomon RE; Brody MJ; Gebhart GF
    J Pharmacol Exp Ther; 1989 Oct; 251(1):27-38. PubMed ID: 2571720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bromocriptine on catecholamine receptors mediating cardiovascular responses in the pithed rat.
    Vila E; Badia A; Jane F
    J Auton Pharmacol; 1985 Jun; 5(2):125-30. PubMed ID: 2991290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.